Tobacco Use and the Risk of Suffering from COVID-19
Keywords:Angiotensin-converting enzyme 2 (ACE2) receptor, cigarette, COVID-19, respiratory virus epidemics, smoking
BACKGROUND: Coronavirus disease (COVID-19) has become a global pandemic and is confirmed worldwide to cause a high mortality rates; as of the April 23, 2020, over 189,000 deaths have occurred in 2,700,800 COVID-19 cases. However, it appears that little consideration has been given to smokers and the users of tobacco-related products relative to the impact of the virus on that particular cohort of patients.
AIM: The aim of the study was to commence a narrative review of research and academic articles of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) prevalence related to cigarette smoking and the consumption of tobacco-related products.
METHODS: The study involved evidence-based publication searches on ProQuest and EBSCOhost databases informed by a number of keywords. The additional data were obtained from relevant journals searched manually, as well as following up references or primary articles. The search was conducted from April 23 to 24, 2020, adopting the use of several terms, such as “tobacco use” AND “COVID”, “tobacco use” AND “SARS-CoV-2”, “smokers” AND “COVID”, “cigarette” AND “SARS-CoV-2”, and “tobacco use” AND COVID-19 AND sars-cov-2.
RESULTS: Several studies (n = 8) confirmed that conventional smoking and electronic cigarette use correlated with the decline of the human immune system and the feasibility of infection. The second group of evidence (n = 9) explored higher Angiotensin-converting enzyme 2 among smokers, as the binding sites of SARS-COV-2.
CONCLUSION: Tobacco use among smokers and former smokers is significantly correlated to the decline in the status of the human immune system and worsen the disease prognosis. In addition, smoking status is associated with a greater likelihood of smokers being infected with SARS-COV-2; a condition that can further develop into coronavirus disease.
Romanov BK. Coronavirus disease COVID-2019. Saf Risk Pharmacother. 2020;8(1):3-8.
Zhang H, Penninger JM, Li Y, Zhong N, Slutsky AS. Angiotensin converting enzyme 2 (ACE2) as a SARS-CoV-2 receptor: Molecular mechanisms and potential therapeutic target. Intensive Care Med. 2020;46(4):586-90. https://doi.org/10.1007/s00134-020-05985-9 PMid:32125455
Chen T, Wu D, Chen H, Yan W, Yang D, Chen G, et al. Clinical characteristics of 113 deceased patients with Coronavirus disease 2019: Retrospective study. BMJ. 2020;368:m1091. https://doi.org/10.1136/bmj.m1091 PMid:32217556
Rabi FA, Al Zoubi MS, Kasasbeh GA, Salameh DM, Al-Nasser AD. SARS-CoV-2 and Coronavirus disease 2019: What we know so far. Pathogens. 2020;9(3):231. https://doi.org/10.3390/pathogens9030231 PMid:32245083
Sarma P, Prajapat M, Avti P, Kaur H, Kumar S, Medhi B. Therapeutic options for the treatment of 2019-novel Coronavirus: An evidence-based approach. Indian J Pharmacol. 2020;52(1):1-5. https://doi.org/10.4103/ijp.ijp_119_20 PMid:32201439
Brake SJ, Barnsley K, Lu W, McAlinden KD, Eapen MS, SohalSS. Smoking upregulates angiotensin-converting enzyme-2 receptor: A potential adhesion site for novel Coronavirus SARS CoV-2 (COVID-19). J Clin Med. 2020;9(3):841. https://doi.org/10.3390/jcm9030841 PMid:32244852
Murukutla N. Communication Strategies for Smokeless Tobacco Control and Prevention. Available from: https://www. untobaccocontrol.org/kh/smokeless-tobacco/wp-content/uploads/sites/6/2017/12/dr.nandita.pdf. [Last accessed on 2021 Mar 03].
World Health Organization. Regional Action Plan for the Tobacco Free Initiative in the Western Pacific (2015-2019). Available from: https://www.apps.who.int/iris/handle/10665/208180.[Last accessed on 2021 Mar 03].
Murukutla N, Strategies V, Turk T. Using Strategic Health Communication for Tobacco Control in India. Available from: https://www.vitalstrategies.org/resources/using-health communication-effectively-for-smokeless-tobacco-control-in ind. [Last accessed on 2021 Mar 03].
Byron MJ, Cohen JE, Frattaroli S, Gittelsohn J, Drope JM, Jernigan DH. Implementing smoke-free policies in low-and middle-income countries: A brief review and research agenda. Tob Induc Dis. 2019;17:60. https://doi.org/10.18332/tid/110007 PMid:31582949
Khan KS, Kunz R, Kleijnen J, Antes G. Five steps to conducting a systematic review. J R Soc Med. 2003;96(3):118-21. https://doi.org/10.1258/jrsm.96.3.118 PMid:12612111
Sandelowski M, Barroso J, Voils CI. Using qualitative metasummary to synthesize qualitative and quantitative descriptive findings. Res Nurs Health. 2007;30(1):99-111. https://doi.org/10.1002/nur.20176 PMid:17243111
Rother ET. Systematic literature review X narrative review. ACTA Paul Enferm. 2007;20(2):7-8.
World Health Organization. Tobacco and Waterpipe use Increase the Risk of Suffering from COVID-19. Geneva: World Health Organization; 2020. p. 10.
Sorour K. ACE-2 in the Highlight of COVID-19, a Proposed Pathology and Potential Correlations, Central Open Science; 2020.
Vardavas C, Nikitara K. COVID-19 and smoking: A systematic review of the evidence. Tob Induc Dis. 2020;18:20. https://doi.org/10.18332/tid/119324 PMid:32206052
Lewis T. Smoking or Vaping May Increase the Risk of a Severe Coronavirus Infection, Scientific American; 2020. p. 1-8. Available from: https://www.scientificamerican.com/article/smoking-or-vaping-may-increase-the-risk-of-a-severe coronavirus-infection1.
Starace F, Ferrara M. COVID-19 disease emergency operational instructions for mental health departments issued by the Italian society of epidemiological psychiatry. Epidemiol Psychiatr Sci. 2020;29:e116. https://doi.org/10.1017/s2045796020000372 PMid:32228737
Jordan RE, Adab P, Cheng KK. COVID-19: Risk factors for severe disease and death. BMJ. 2020;368:m1198. https://doi.org/10.1136/bmj.m1198 PMid:32217618
Leung JM, Yang CX, Tam A, Shaipanich T, Hackett TL, SingheraGK, et al. ACE-2 Expression in the Small Airway Epithelia of Smokers and COPD Patients: Implications for COVID-19, medRxiv; 2020. https://doi.org/10.1183/13993003.00688-2020
Wang J, Luo Q, Chen R, Chen T, Li J. Susceptibility Analysis of COVID-19 in Smokers Based on ACE2; 2020. p. 1-8.
Zhou P, Lou YX, Wang XG, Hu B, Zhang L, Zhang W, et al. A pneumonia outbreak associated with a new Coronavirus of probable bat origin. Nature. 2020;579(7798):270-3 PMid:32015507
Simons D, Perski O, Brown J. COVID-19: The role of smoking cessation during respiratory virus epidemics. BMJ. 2020;2020:20-2.
Meo SA, AlShehri KA, AlHarbi BB, Barayyan OR, Bawazir AS, Alanazi OA, et al. Effect of shisha (waterpipe) smoking on lung functions and fractional exhaled nitric oxide (FeNO) among Saudi young adult shisha smokers. Int J Environ Res Public Health. 2014;11(9):9638-48. https://doi.org/10.3390/ijerph110909638 PMid:25233010
Sohal SS, Eapen MS, Naidu VG, Sharma P. IQOS exposure impairs human airway cell homeostasis: Direct comparison with traditional cigarette and E-cigarette. ERJ Open Res. 2019;5(1):00159-2018. https://doi.org/10.1183/23120541.00159-2018 PMid:30775377
Cai G, Cui X, Zhu X, Zhou J. A Hint on the COVID-19 Risk: Population Disparities in Gene Expression of Three Receptors of SARS-CoV; 2020. https://doi.org/10.20944/preprints202002.0408.v1
How to Cite
Copyright (c) 2021 Dianita Sugiyo, Ralalicia Limato, Saskia Dyah Handari (Author)
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
All rights reserved.